Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prokidney (PROK) Operating Leases (2022 - 2025)

Prokidney (PROK) has disclosed Operating Leases for 4 consecutive years, with $3.5 million as the latest value for Q2 2025.

  • On a quarterly basis, Operating Leases changed N/A to $3.5 million in Q2 2025 year-over-year; TTM through Jun 2025 was $3.5 million, a N/A change, with the full-year FY2024 number at $2.5 million, down 31.55% from a year prior.
  • Operating Leases was $3.5 million for Q2 2025 at Prokidney, up from $2.5 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $5.4 million in Q3 2024 to a low of $1.9 million in Q4 2022.
  • A 4-year average of $3.2 million and a median of $2.5 million in 2025 define the central range for Operating Leases.
  • Peak YoY movement for Operating Leases: surged 154.72% in 2024, then tumbled 48.3% in 2025.
  • Prokidney's Operating Leases stood at $1.9 million in 2022, then soared by 89.4% to $3.6 million in 2023, then crashed by 31.55% to $2.5 million in 2024, then soared by 42.25% to $3.5 million in 2025.
  • Per Business Quant, the three most recent readings for PROK's Operating Leases are $3.5 million (Q2 2025), $2.5 million (Q1 2025), and $2.5 million (Q4 2024).